0000939767-16-000274.txt : 20161114 0000939767-16-000274.hdr.sgml : 20161111 20161114193759 ACCESSION NUMBER: 0000939767-16-000274 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161109 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRISSEY MICHAEL CENTRAL INDEX KEY: 0001202096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 161997416 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL M DATE OF NAME CHANGE: 20030512 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL R DATE OF NAME CHANGE: 20021029 4 1 wf-form4_147917026535534.xml FORM 4 X0306 4 2016-11-09 0 0000939767 EXELIXIS, INC. EXEL 0001202096 MORRISSEY MICHAEL C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Common Stock 2016-11-09 4 M 0 200000 8.99 A 260000 D Common Stock 2016-11-09 4 S 0 200000 15 D 60000 D Common Stock 174698 I By Trust Common Stock 16631 I By 401(k) Option (right to buy) 8.99 2016-11-09 4 M 0 200000 0 D 2007-12-08 2016-12-07 Common Stock 200000.0 0 D Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2016. Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Represents 16,631 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 9, 2016. The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 8, 2010. /s/ Jeffrey J. Hessekiel, Attorney in Fact 2016-11-14